国际共识分类与第五版世界卫生组织分类中T细胞淋巴瘤及组织细胞/树突状细胞肿瘤的比较
本文回顾并比较了国际共识分类(ICC)与第五版世界卫生组织分类(WHO-HAEM5)在T细胞淋巴瘤及组织细胞/树突状细胞肿瘤中的诊断标准和实体定义,并更新了各病理实体的遗传学数据,旨在为病理学家、血液学家和研究人员提供便于诊断和治疗的工具。
要点
- ICC与WHO-HAEM5在T细胞淋巴瘤及组织细胞/树突状细胞肿瘤的诊断标准和实体定义上存在差异。
- 本文更新了各病理实体的遗传学数据。
- 比较旨在辅助病理学家、血液学家和研究人员的诊断与治疗工作。
核心结论
- 本文比较了ICC与WHO-HAEM5在T细胞淋巴瘤及组织细胞/树突状细胞肿瘤中的诊断标准和实体定义,并更新了遗传学数据,以辅助诊断和治疗。
研究设计与样本
- 本文为综述,回顾并比较ICC与WHO-HAEM5两种分类在T细胞淋巴瘤及组织细胞/树突状细胞肿瘤中的诊断标准和实体定义。
主要发现
- 自2017年WHO-HAEM4发布以来,淋巴瘤领域的临床病理、免疫表型和分子进展促成了ICC和WHO-HAEM5两个分类提案。
- 本文聚焦于T细胞淋巴瘤及组织细胞/树突状细胞肿瘤,比较了两种分类的诊断标准和实体定义。
- 本文更新了各病理实体的遗传学数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since the publication in 2017 of the revised 4th Edition of the World Health Organization (WHO) classification of haematolymphoid tumours, here referred to as WHO-HAEM4, significant clinicopathological, immunophenotypic and molecular advances have been made in the field of lymphomas, contributing to refining the diagnostic criteria of several diseases, upgrading entities previously defined as provisional and identifying new entities. This process has resulted in two recent classification proposals of lymphoid neoplasms: the International Consensus Classification (ICC) and the 5th edition of the WHO classification (WHO-HAEM5). In this paper, we review and compare the two classifications in terms of diagnostic criteria and entity definition, focusing on T-cell lymphomas and histiocytic/dendritic cell tumours. Moreover, we update the genetic data of the various pathological entities. The main goal is to provide a tool to facilitate the work of the pathologists, haematologists and researchers involved in the diagnosis and treatment of these haematological malignancies.
引用
- Falini B, Lazzi S, Pileri S, et al. A comparison of the International Consensus and 5th WHO classifications of T-cell lymphomas and histiocytic/dendritic cell tumours. Br J Haematol. 2023. PMID: 37387351. doi:10.1111/bjh.18940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。